Document Detail


Expression of urokinase-type plasminogen-activator (upa) and its receptor (upar) in human ovarian-cancer cells and in-vitro invasion capacity.
MedLine Citation:
PMID:  21559638     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Expression of urokinase-type plasminogen activator (uPA), tissue-type plasminogen activator (t-PA), their inhibitor PAI-1 and the uPA-receptor (uPAR) was characterized in six human tumor cell lines (OV-MZ-6, -10, -13, -15, -19 and OVCAR-3) established from patients with cystadenocarcinoma of the ovary. The invasive potential of the ovarian cancer cell lines determined in an in vitro invasion assay did neither correlate with the antigen level of uPA, t-PA, PAI-1 or uPAR nor with the cell surface uPA activity, however, did correlate with the cell surface-bound plasmin activity. The in vitro invasiveness of three cancer cell lines selected displaying a different pattern of uPA and uPAR expression was significantly inhibited by a recombinant soluble truncated form of the uPAR functioning as a scavenger for uPA. Our results suggest that the interference of the uPA/uPAR interaction leads to a reduced in vitro invasiveness of human ovarian cancer cells independent of the level of uPA and uPAR expression.
Authors:
C Will; O Wilhelm; S Hohl; V Mobus; U Weidle; R Kreienberg; F Janicke; M Schmitt; H Graeff
Related Documents :
21189468 - Improved visualization and quantitative analysis of drug effects using micropatterned c...
21445878 - Down-regulation of bmi-1 cooperates with artemisinin on growth inhibition of nasopharyn...
21552288 - Mir-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.
25157278 - Molecular imaging in tracking tumor-specific cytotoxic t lymphocytes (ctls).
16618928 - Designing a nano-interface in a microfluidic chip to probe living cells: challenges and...
10672898 - Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of oncology     Volume:  5     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  1994 Oct 
Date Detail:
Created Date:  2011-05-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  753-61     Citation Subset:  -    
Affiliation:
TECH UNIV MUNICH, KLINIKUM RECHTS ISAR, FRAUENKLIN, D-81675 MUNICH, GERMANY. UNIV ULM, FRAUENKLIN, D-89075 ULM, GERMANY. BOEHRINGER MANNHEIM GMBH, D-82377 PENZBERG, GERMANY.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The presence of herpesviruses in pterygium.
Next Document:  Tumor vascular shutdown following photodynamic therapy based on polyhematoporphyrin or 5-aminolevuli...